Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA039854-04S1
Application #
3179229
Study Section
Experimental Immunology Study Section (EI)
Project Start
1984-09-01
Project End
1991-07-31
Budget Start
1987-08-01
Budget End
1988-07-31
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Medical College of Wisconsin
Department
Type
Schools of Medicine
DUNS #
073134603
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
LaBelle, James L; Truitt, Robert L (2002) Characterization of a murine NKT cell tumor previously described as an acute myelogenous leukemia. Leuk Lymphoma 43:1637-44
Johnson, Bryon D; Konkol, Marja C; Truitt, Robert L (2002) CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Biol Blood Marrow Transplant 8:525-35
LaBelle, James L; Hanke, Carrie A; Blazar, Bruce R et al. (2002) Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia. Blood 99:2146-53
Johnson, B D; Dagher, N; Stankowski, W C et al. (2001) Donor natural killer (NK1.1+) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI. Biol Blood Marrow Transplant 7:589-95
Johnson, B D; Becker, E E; LaBelle, J L et al. (1999) Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. J Immunol 163:6479-87
Johnson, B D; Becker, E E; Truitt, R L (1999) Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets. Biol Blood Marrow Transplant 5:123-32
Truitt, R L; Johnson, B D; Hanke, C et al. (1999) Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation. J Immunol 163:5145-56
Johnson, B D; Hanke, C A; Becker, E E et al. (1998) Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro. Cell Immunol 189:149-59
Johnson, B D; Truitt, R L (1995) Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease. Blood 85:3302-12
Casper, J; Camitta, B; Truitt, R et al. (1995) Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 85:2354-63

Showing the most recent 10 out of 23 publications